Holen Sie sich die Stockscreener-App
17.75
1.43%
0.25
Schlusskurs vom Vortag:
$17.50
Offen:
$17.41
24-Stunden-Volumen:
21,736
Relative Volume:
0.31
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.72%
1M Leistung:
+9.43%
6M Leistung:
-33.09%
1J Leistung:
-36.18%
1-Tages-Spanne:
$17.41
$17.89
1-Wochen-Bereich:
$16.85
$18.39
52-Wochen-Spanne:
$13.42
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Firmenname
Virtus Lifesci Biotech Clinical Trials Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
17.75 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
292.58 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
594.20 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
597.04 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
234.74 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
521.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Aktie (BBC) Neueste Nachrichten
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBC) Trading Signals - Stock Traders Daily
(BBC) Trading Advice - Stock Traders Daily
(BBC) Proactive Strategies - Stock Traders Daily
Stock Market Movers Today • Top Gainers & Losers - Benzinga
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Long Term Investment Analysis - Stock Traders Daily
How to Take Advantage of moves in (BBC) - Stock Traders Daily
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
The Great Rotation: Just Getting Started? - ETF Trends
5 Top ETFs of Last Week - Nasdaq
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
9 Best Biotech ETFs for 2024 - MSN
The 5 Best Biotech ETFs of 2024 - ETF.com
5 Best ETF Areas of Last Week - Nasdaq
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Top and Flop Industry ETFs of Q3 - Nasdaq
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
ALPS’ Biotech ETF SBIO Week’s Top Performer - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - Financial Advisor (Mag)
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Biotech ETFs Are Making a Comeback - ETF Trends
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Yahoo Finance
Betting on Biotech Bear Market Expiration Date - ETF Trends
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Positioning for Biotech Bounceback - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
ETF Exchange: Latest ETF News & Insights | Pensions & Investments - Pensions & Investments
Biotech Ready to Participate in Healthcare Bullishness - Nasdaq
Drug Price Debate Might Not Hinder Biotech ETFs - ETFdb.com
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - etf.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News - Zacks Investment Research
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Yahoo Finance
After AstraZeneca, Oxford Nanopore Might Be The Next UK COVID Winner - Investing.com
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
Unless Sorrento Makes Solid Progress Soon, It Will Likely Go Below $5 - Nasdaq
A Healthcare ETF Review: Biotech Beckons under Biden - ETF Trends
Medical Breakthrough ETFs for More than Just COVID - ETF Database
Finanzdaten der Virtus Lifesci Biotech Clinical Trials Etf-Aktie (BBC)
Es liegen keine Finanzdaten für Virtus Lifesci Biotech Clinical Trials Etf (BBC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):